By the same authors

From the same journal

From the same journal

Accelerating Innovation in the Creation of Biovalue: The Cell and Gene Therapy Catapult

Research output: Contribution to journalArticlepeer-review

Full text download(s)

Published copy (DOI)



Publication details

JournalScience, Technology and Human Values
DateIn preparation - 1 Mar 2017
DateAccepted/In press - 1 Mar 2017
DateE-pub ahead of print - 6 Apr 2017
DatePublished (current) - 6 Apr 2017
Early online date6/04/17
Original languageEnglish


The field of regenerative medicine (RM) has considerable therapeutic promise that is proving difficult to realize. As a result, governments have supported the establishment of intermediary agencies to “accelerate” innovation. This paper examines in detail one such agency, the UK's Cell and Gene Therapy Catapult (CGTC). We describe CGTC’s role as an accelerator agency and its value-narrative, which combines both “health and wealth.” Drawing on the notion of socio-technical imaginaries, we unpack the tensions within this narrative and its instantiation as the CGTC cell therapy infrastructure is built and engages with other agencies, some of which have different priorities and roles to play within the RM field.


Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations